| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.2B | $8.0B | $6.9B | $5.7B | $5.0B | $1.3B | $0.0B | $0.0B |
| Cost of Revenue | $6.5B | $5.1B | $4.5B | $4.1B | $3.5B | $0.9B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.2B | — | — |
| SG&A Expense | $1.6B | $1.4B | $1.3B | $1.2B | $1.1B | $0.3B | — | — |
| Operating Income | $1.8B | $1.4B | $0.9B | $0.2B | $0.3B | — | — | — |
| Net Income | $1.3B | $0.5B | $0.5B | $0.1B | $0.1B | $0.1B | $-0.0B | $0.0B |
| EPS (Basic) | $3.49 | $1.32 | $1.21 | $0.20 | $0.34 | $0.23 | — | — |
| EPS (Diluted) | $3.41 | $1.28 | $1.19 | $-0.04 | $0.33 | $0.22 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2B | $9.1B | $8.0B | $7.1B | $6.9B | $5.1B | $0.7B | $0.7B |
| Current Assets | $6.8B | $5.1B | $4.0B | $3.2B | $2.7B | $2.5B | $0.7B | $0.0B |
| Cash & Equivalents | $1.7B | $1.2B | $0.8B | $0.3B | $0.4B | $0.5B | $0.0B | $0.0B |
| Total Liabilities | $8.3B | $6.7B | $6.0B | $5.7B | $5.5B | $4.4B | $0.0B | $0.0B |
| Current Liabilities | $4.4B | $3.1B | $2.3B | $1.9B | $1.9B | $1.7B | $0.0B | $0.0B |
| Stockholders' Equity | $3.9B | $2.4B | $2.0B | $1.4B | $1.4B | $0.7B | $0.0B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $1.3B | $0.9B | $-0.2B | $0.2B | $0.2B | $0.0B | $-0.0B |
| Investing Cash Flow | $-1.5B | $-0.2B | $-0.1B | $-0.1B | $-1.2B | $-0.0B | — | $-0.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B | — | — |
| Financing Cash Flow | $-0.1B | $-0.7B | $-0.2B | $0.1B | $0.9B | $0.1B | $0.0B | $0.7B |